Silo Pharma

SILONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.016 M

$1.72 -1.43%

Close of 22 Sept 2026

Revenue

$72.1K

#3599 by revenue

Earnings

-$4.23M

Loss-making

Shares outstanding

1,588,250

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#483China SXT PharmaceuticalsSXTC$3.26M
#484Alaunos TherapeuticsTCRT$3.23M
#485Silo PharmaSILO$3.02M
#486OnconetixONCO$2.99M
#487GenprexGNPX$2.90M

What if Silo Pharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$17,244,529

Per share 10,025,889× higher

Bitcoin $1.74T

$993,386.60

Per share 577,550× higher

Nvidia $5.52T

$3,146,024

Per share 1,829,084× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Silo Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.